Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 141 entries
Sorted by: Best Match Show Resources per page
The Yin and Yang of the Bone Marrow Microenvironment: Pros and Cons of Mesenchymal Stromal Cells in Acute Myeloid Leukemia.

Frontiers in oncology

Ciciarello M, Corradi G, Loscocco F, Visani G, Monaco F, Cavo M, Curti A, Isidori A.
PMID: 31709192
Front Oncol. 2019 Oct 25;9:1135. doi: 10.3389/fonc.2019.01135. eCollection 2019.

Mesenchymal stromal cells (MSCs) have, for a long time, been recognized as pivotal contributors in the set up and maintenance of the hematopoietic stem cell (HSC) niche, as well as in the development and differentiation of the lympho-hematopoietic system....

Cite
Ciciarello M, Corradi G, Loscocco F, et al. The Yin and Yang of the Bone Marrow Microenvironment: Pros and Cons of Mesenchymal Stromal Cells in Acute Myeloid Leukemia. Front Oncol. 2019;9:1135doi: 10.3389/fonc.2019.01135.
Ciciarello, M., Corradi, G., Loscocco, F., Visani, G., Monaco, F., Cavo, M., Curti, A., & Isidori, A. (2019). The Yin and Yang of the Bone Marrow Microenvironment: Pros and Cons of Mesenchymal Stromal Cells in Acute Myeloid Leukemia. Frontiers in oncology, 91135. https://doi.org/10.3389/fonc.2019.01135
Ciciarello, Marilena, et al. "The Yin and Yang of the Bone Marrow Microenvironment: Pros and Cons of Mesenchymal Stromal Cells in Acute Myeloid Leukemia." Frontiers in oncology vol. 9 (2019): 1135. doi: https://doi.org/10.3389/fonc.2019.01135
Ciciarello M, Corradi G, Loscocco F, Visani G, Monaco F, Cavo M, Curti A, Isidori A. The Yin and Yang of the Bone Marrow Microenvironment: Pros and Cons of Mesenchymal Stromal Cells in Acute Myeloid Leukemia. Front Oncol. 2019 Oct 25;9:1135. doi: 10.3389/fonc.2019.01135. eCollection 2019. PMID: 31709192; PMCID: PMC6823864.
Copy Download .nbib Format: NLM
Clinical evidence of abscopal effect in cutaneous squamous cell carcinoma treated with diffusing alpha emitters radiation therapy: a case report.

Journal of contemporary brachytherapy

Bellia SR, Feliciani G, Duca MD, Monti M, Turri V, Sarnelli A, Romeo A, Kelson I, Keisari Y, Popovtzer A, Ibrahim T, Paganelli G, Stanganelli I.
PMID: 31749854
J Contemp Brachytherapy. 2019 Oct;11(5):449-457. doi: 10.5114/jcb.2019.88138. Epub 2019 Oct 30.

PURPOSE: Alpha particle treatments could enhance the probability of an immune response, which can lead to abscopal effects (AE). We report a case of a patient affected by multiple cutaneous squamous cell carcinoma (cSCC). After the treatment with diffusing...

Cite
Bellia SR, Feliciani G, Duca MD, et al. Clinical evidence of abscopal effect in cutaneous squamous cell carcinoma treated with diffusing alpha emitters radiation therapy: a case report. J Contemp Brachytherapy. 2019;11(5):449-457doi: 10.5114/jcb.2019.88138.
Bellia, S. R., Feliciani, G., Duca, M. D., Monti, M., Turri, V., Sarnelli, A., Romeo, A., Kelson, I., Keisari, Y., Popovtzer, A., Ibrahim, T., Paganelli, G., & Stanganelli, I. (2019). Clinical evidence of abscopal effect in cutaneous squamous cell carcinoma treated with diffusing alpha emitters radiation therapy: a case report. Journal of contemporary brachytherapy, 11(5), 449-457. https://doi.org/10.5114/jcb.2019.88138
Bellia, Salvatore Roberto, et al. "Clinical evidence of abscopal effect in cutaneous squamous cell carcinoma treated with diffusing alpha emitters radiation therapy: a case report." Journal of contemporary brachytherapy vol. 11,5 (2019): 449-457. doi: https://doi.org/10.5114/jcb.2019.88138
Bellia SR, Feliciani G, Duca MD, Monti M, Turri V, Sarnelli A, Romeo A, Kelson I, Keisari Y, Popovtzer A, Ibrahim T, Paganelli G, Stanganelli I. Clinical evidence of abscopal effect in cutaneous squamous cell carcinoma treated with diffusing alpha emitters radiation therapy: a case report. J Contemp Brachytherapy. 2019 Oct;11(5):449-457. doi: 10.5114/jcb.2019.88138. Epub 2019 Oct 30. PMID: 31749854; PMCID: PMC6854861.
Copy Download .nbib Format: NLM
Clinical Relevance of ABCB1, ABCG2, and ABCC2 Gene Polymorphisms in Chronic Myeloid Leukemia Patients Treated With Nilotinib.

Frontiers in oncology

Loscocco F, Visani G, Ruzzo A, Bagaloni I, Fuligni F, Galimberti S, Di Paolo A, Stagno F, Pregno P, Annunziata M, Gozzini A, Barulli S, Gabucci E, Magnani M, Isidori A.
PMID: 34055641
Front Oncol. 2021 May 13;11:672287. doi: 10.3389/fonc.2021.672287. eCollection 2021.

Tyrosine kinase inhibitors (TKIs) have radically changed the outcome of chronic myeloid leukemia (CML) patients in the last 20 years. Moreover, the advent of second generation TKIs, namely nilotinib and dasatinib, have largely increased the number of CML patients...

Cite
Loscocco F, Visani G, Ruzzo A, et al. Clinical Relevance of ABCB1, ABCG2, and ABCC2 Gene Polymorphisms in Chronic Myeloid Leukemia Patients Treated With Nilotinib. Front Oncol. 2021;11:672287doi: 10.3389/fonc.2021.672287.
Loscocco, F., Visani, G., Ruzzo, A., Bagaloni, I., Fuligni, F., Galimberti, S., Di Paolo, A., Stagno, F., Pregno, P., Annunziata, M., Gozzini, A., Barulli, S., Gabucci, E., Magnani, M., & Isidori, A. (2021). Clinical Relevance of ABCB1, ABCG2, and ABCC2 Gene Polymorphisms in Chronic Myeloid Leukemia Patients Treated With Nilotinib. Frontiers in oncology, 11672287. https://doi.org/10.3389/fonc.2021.672287
Loscocco, Federica, et al. "Clinical Relevance of ABCB1, ABCG2, and ABCC2 Gene Polymorphisms in Chronic Myeloid Leukemia Patients Treated With Nilotinib." Frontiers in oncology vol. 11 (2021): 672287. doi: https://doi.org/10.3389/fonc.2021.672287
Loscocco F, Visani G, Ruzzo A, Bagaloni I, Fuligni F, Galimberti S, Di Paolo A, Stagno F, Pregno P, Annunziata M, Gozzini A, Barulli S, Gabucci E, Magnani M, Isidori A. Clinical Relevance of ABCB1, ABCG2, and ABCC2 Gene Polymorphisms in Chronic Myeloid Leukemia Patients Treated With Nilotinib. Front Oncol. 2021 May 13;11:672287. doi: 10.3389/fonc.2021.672287. eCollection 2021. PMID: 34055641; PMCID: PMC8155509.
Copy Download .nbib Format: NLM
Structural Changes in the Optic Disc and Macula Detected by Swept-Source Optical Coherence Tomography After Surgical Intraocular Pressure Reduction in Patients with Open-Angle Glaucoma.

Clinical ophthalmology (Auckland, N.Z.)

Vessani R, Frota T, Shigetomi G, Correa P, Mariottoni EB, Tavares I.
PMID: 34285468
Clin Ophthalmol. 2021 Jul 14;15:3017-3026. doi: 10.2147/OPTH.S317190. eCollection 2021.

PURPOSE: To evaluate the magnitude of change in optic disc, peripapillary retinal nerve fiber layer (RNFL) and macular parameters measured by swept-source optical coherence tomography (SS-OCT) in glaucomatous eyes after filtration surgery, and to determine any possible relationship between...

Cite
Vessani R, Frota T, Shigetomi G, et al. Structural Changes in the Optic Disc and Macula Detected by Swept-Source Optical Coherence Tomography After Surgical Intraocular Pressure Reduction in Patients with Open-Angle Glaucoma. Clin Ophthalmol. 2021;15:3017-3026doi: 10.2147/OPTH.S317190.
Vessani, R., Frota, T., Shigetomi, G., Correa, P., Mariottoni, E. B., & Tavares, I. (2021). Structural Changes in the Optic Disc and Macula Detected by Swept-Source Optical Coherence Tomography After Surgical Intraocular Pressure Reduction in Patients with Open-Angle Glaucoma. Clinical ophthalmology (Auckland, N.Z.), 153017-3026. https://doi.org/10.2147/OPTH.S317190
Vessani, Roberto, et al. "Structural Changes in the Optic Disc and Macula Detected by Swept-Source Optical Coherence Tomography After Surgical Intraocular Pressure Reduction in Patients with Open-Angle Glaucoma." Clinical ophthalmology (Auckland, N.Z.) vol. 15 (2021): 3017-3026. doi: https://doi.org/10.2147/OPTH.S317190
Vessani R, Frota T, Shigetomi G, Correa P, Mariottoni EB, Tavares I. Structural Changes in the Optic Disc and Macula Detected by Swept-Source Optical Coherence Tomography After Surgical Intraocular Pressure Reduction in Patients with Open-Angle Glaucoma. Clin Ophthalmol. 2021 Jul 14;15:3017-3026. doi: 10.2147/OPTH.S317190. eCollection 2021. PMID: 34285468; PMCID: PMC8286732.
Copy Download .nbib Format: NLM
Immunotherapy in Acute Myeloid Leukemia: Where We Stand.

Frontiers in oncology

Isidori A, Cerchione C, Daver N, DiNardo C, Garcia-Manero G, Konopleva M, Jabbour E, Ravandi F, Kadia T, Burguera AF, Romano A, Loscocco F, Visani G, Martinelli G, Kantarjian H, Curti A.
PMID: 34041025
Front Oncol. 2021 May 10;11:656218. doi: 10.3389/fonc.2021.656218. eCollection 2021.

In the past few years, our improved knowledge of acute myeloid leukemia (AML) pathogenesis has led to the accelerated discovery of new drugs and the development of innovative therapeutic approaches. The role of the immune system in AML development,...

Cite
Isidori A, Cerchione C, Daver N, et al. Immunotherapy in Acute Myeloid Leukemia: Where We Stand. Front Oncol. 2021;11:656218doi: 10.3389/fonc.2021.656218.
Isidori, A., Cerchione, C., Daver, N., DiNardo, C., Garcia-Manero, G., Konopleva, M., Jabbour, E., Ravandi, F., Kadia, T., Burguera, A. F., Romano, A., Loscocco, F., Visani, G., Martinelli, G., Kantarjian, H., & Curti, A. (2021). Immunotherapy in Acute Myeloid Leukemia: Where We Stand. Frontiers in oncology, 11656218. https://doi.org/10.3389/fonc.2021.656218
Isidori, Alessandro, et al. "Immunotherapy in Acute Myeloid Leukemia: Where We Stand." Frontiers in oncology vol. 11 (2021): 656218. doi: https://doi.org/10.3389/fonc.2021.656218
Isidori A, Cerchione C, Daver N, DiNardo C, Garcia-Manero G, Konopleva M, Jabbour E, Ravandi F, Kadia T, Burguera AF, Romano A, Loscocco F, Visani G, Martinelli G, Kantarjian H, Curti A. Immunotherapy in Acute Myeloid Leukemia: Where We Stand. Front Oncol. 2021 May 10;11:656218. doi: 10.3389/fonc.2021.656218. eCollection 2021. PMID: 34041025; PMCID: PMC8143531.
Copy Download .nbib Format: NLM
Metabolic Switch and Cytotoxic Effect of Metformin on Burkitt Lymphoma.

Frontiers in oncology

Bagaloni I, Visani A, Biagiotti S, Ruzzo A, Navari M, Etebari M, Mundo L, Granai M, Lazzi S, Isidori A, Loscocco F, Li J, Leoncini L, Visani G, Magnani M, Piccaluga PP.
PMID: 34557403
Front Oncol. 2021 Sep 02;11:661102. doi: 10.3389/fonc.2021.661102. eCollection 2021.

Altered cellular energetic metabolism has recently emerged as important feature of neoplastic cells. Indeed, interfering with cancer cell metabolism might represent a suitable therapeutic strategy. In this study, we aimed to assess glucose metabolism activation in human lymphomas and...

Cite
Bagaloni I, Visani A, Biagiotti S, et al. Metabolic Switch and Cytotoxic Effect of Metformin on Burkitt Lymphoma. Front Oncol. 2021;11:661102doi: 10.3389/fonc.2021.661102.
Bagaloni, I., Visani, A., Biagiotti, S., Ruzzo, A., Navari, M., Etebari, M., Mundo, L., Granai, M., Lazzi, S., Isidori, A., Loscocco, F., Li, J., Leoncini, L., Visani, G., Magnani, M., & Piccaluga, P. P. (2021). Metabolic Switch and Cytotoxic Effect of Metformin on Burkitt Lymphoma. Frontiers in oncology, 11661102. https://doi.org/10.3389/fonc.2021.661102
Bagaloni, Irene, et al. "Metabolic Switch and Cytotoxic Effect of Metformin on Burkitt Lymphoma." Frontiers in oncology vol. 11 (2021): 661102. doi: https://doi.org/10.3389/fonc.2021.661102
Bagaloni I, Visani A, Biagiotti S, Ruzzo A, Navari M, Etebari M, Mundo L, Granai M, Lazzi S, Isidori A, Loscocco F, Li J, Leoncini L, Visani G, Magnani M, Piccaluga PP. Metabolic Switch and Cytotoxic Effect of Metformin on Burkitt Lymphoma. Front Oncol. 2021 Sep 02;11:661102. doi: 10.3389/fonc.2021.661102. eCollection 2021. PMID: 34557403; PMCID: PMC8454268.
Copy Download .nbib Format: NLM
Long term results of Dorsal Root Entry Zone (DREZ) lesions for the treatment of intractable pain: A systematic review of the literature on 1242 cases.

Clinical neurology and neurosurgery

Mongardi L, Visani J, Mantovani G, Vitali C, Ricciardi L, Giordano F, Cavallo MA, Lofrese G, D'andrea M, Roblot P, De Bonis P, Scerrati A.
PMID: 34739884
Clin Neurol Neurosurg. 2021 Nov;210:107004. doi: 10.1016/j.clineuro.2021.107004. Epub 2021 Oct 24.

BACKGROUND: Different Dorsal root entry zone (DREZ) lesion techniques have been reported as effective treatment for intractable painful conditions, though with contradictory results. Overall, good results were reported especially in specific conditions, such as pain due to brachial plexus...

Cite
Mongardi L, Visani J, Mantovani G, et al. Long term results of Dorsal Root Entry Zone (DREZ) lesions for the treatment of intractable pain: A systematic review of the literature on 1242 cases. Clin Neurol Neurosurg. 2021;210:107004doi: 10.1016/j.clineuro.2021.107004.
Mongardi, L., Visani, J., Mantovani, G., Vitali, C., Ricciardi, L., Giordano, F., Cavallo, M. A., Lofrese, G., D'andrea, M., Roblot, P., De Bonis, P., & Scerrati, A. (2021). Long term results of Dorsal Root Entry Zone (DREZ) lesions for the treatment of intractable pain: A systematic review of the literature on 1242 cases. Clinical neurology and neurosurgery, 210107004. https://doi.org/10.1016/j.clineuro.2021.107004
Mongardi, Lorenzo, et al. "Long term results of Dorsal Root Entry Zone (DREZ) lesions for the treatment of intractable pain: A systematic review of the literature on 1242 cases." Clinical neurology and neurosurgery vol. 210 (2021): 107004. doi: https://doi.org/10.1016/j.clineuro.2021.107004
Mongardi L, Visani J, Mantovani G, Vitali C, Ricciardi L, Giordano F, Cavallo MA, Lofrese G, D'andrea M, Roblot P, De Bonis P, Scerrati A. Long term results of Dorsal Root Entry Zone (DREZ) lesions for the treatment of intractable pain: A systematic review of the literature on 1242 cases. Clin Neurol Neurosurg. 2021 Nov;210:107004. doi: 10.1016/j.clineuro.2021.107004. Epub 2021 Oct 24. PMID: 34739884.
Copy Download .nbib Format: NLM
Transpars approach for L5-S1 foraminal and extra-foraminal lumbar disc herniations: technical note.

Journal of neurosurgical sciences

De Bonis P, Musio A, Mongardi L, Lofrese G, La Marca F, Visani J, Cavallo MA, Scerrati A.
PMID: 33297610
J Neurosurg Sci. 2020 Dec 09; doi: 10.23736/S0390-5616.20.05165-6. Epub 2020 Dec 09.

BACKGROUND: The short pars and the narrowed surgical corridor for far lateral L5S1 herniation make the transpars approach challenging. The aim of this study is to determine the feasibility, efficacy and safety of the transpars microscopic approach for the...

Cite
De Bonis P, Musio A, Mongardi L, et al. Transpars approach for L5-S1 foraminal and extra-foraminal lumbar disc herniations: technical note. J Neurosurg Sci. 2020;doi: 10.23736/S0390-5616.20.05165-6.
De Bonis, P., Musio, A., Mongardi, L., Lofrese, G., La Marca, F., Visani, J., Cavallo, M. A., & Scerrati, A. (2020). Transpars approach for L5-S1 foraminal and extra-foraminal lumbar disc herniations: technical note. Journal of neurosurgical sciences, . https://doi.org/10.23736/S0390-5616.20.05165-6
De Bonis, Pasquale, et al. "Transpars approach for L5-S1 foraminal and extra-foraminal lumbar disc herniations: technical note." Journal of neurosurgical sciences vol. (2020). doi: https://doi.org/10.23736/S0390-5616.20.05165-6
De Bonis P, Musio A, Mongardi L, Lofrese G, La Marca F, Visani J, Cavallo MA, Scerrati A. Transpars approach for L5-S1 foraminal and extra-foraminal lumbar disc herniations: technical note. J Neurosurg Sci. 2020 Dec 09; doi: 10.23736/S0390-5616.20.05165-6. Epub 2020 Dec 09. PMID: 33297610.
Copy Download .nbib Format: NLM
Correction: Visani et al. miR-196B-5P and miR-200B-3P Are Differentially Expressed in Medulloblastomas of Adults and Children. .

Diagnostics (Basel, Switzerland)

Visani M, Marucci G, de Biase D, Giangaspero F, Buttarelli FR, Brandes AA, Franceschi E, Acquaviva G, Ciarrocchi A, Rhoden KJ, Tallini G, Pession A.
PMID: 34574077
Diagnostics (Basel). 2021 Sep 07;11(9). doi: 10.3390/diagnostics11091633.

The authors wish to make the following corrections to this paper [...].

Cite
Visani M, Marucci G, de Biase D, et al. Correction: Visani et al. miR-196B-5P and miR-200B-3P Are Differentially Expressed in Medulloblastomas of Adults and Children. . Diagnostics (Basel). 2021;11(9)doi: 10.3390/diagnostics11091633.
Visani, M., Marucci, G., de Biase, D., Giangaspero, F., Buttarelli, F. R., Brandes, A. A., Franceschi, E., Acquaviva, G., Ciarrocchi, A., Rhoden, K. J., Tallini, G., & Pession, A. (2021). Correction: Visani et al. miR-196B-5P and miR-200B-3P Are Differentially Expressed in Medulloblastomas of Adults and Children. . Diagnostics (Basel, Switzerland), 11(9), . https://doi.org/10.3390/diagnostics11091633
Visani, Michela, et al. "Correction: Visani et al. miR-196B-5P and miR-200B-3P Are Differentially Expressed in Medulloblastomas of Adults and Children. ." Diagnostics (Basel, Switzerland) vol. 11,9 (2021). doi: https://doi.org/10.3390/diagnostics11091633
Visani M, Marucci G, de Biase D, Giangaspero F, Buttarelli FR, Brandes AA, Franceschi E, Acquaviva G, Ciarrocchi A, Rhoden KJ, Tallini G, Pession A. Correction: Visani et al. miR-196B-5P and miR-200B-3P Are Differentially Expressed in Medulloblastomas of Adults and Children. . Diagnostics (Basel). 2021 Sep 07;11(9). doi: 10.3390/diagnostics11091633. PMID: 34574077; PMCID: PMC8472253.
Copy Download .nbib Format: NLM
Nano-Based Biomaterials as Drug Delivery Systems Against Osteoporosis: A Systematic Review of Preclinical and Clinical Evidence.

Nanomaterials (Basel, Switzerland)

Salamanna F, Gambardella A, Contartese D, Visani A, Fini M.
PMID: 33669621
Nanomaterials (Basel). 2021 Feb 19;11(2). doi: 10.3390/nano11020530.

Osteoporosis (OP) is one of the most significant causes of morbidity, particularly in post-menopausal women and older men. Despite its remarkable occurrence, the search for an effective treatment is still an open challenge. Here, we systematically reviewed the preclinical...

Cite
Salamanna F, Gambardella A, Contartese D, et al. Nano-Based Biomaterials as Drug Delivery Systems Against Osteoporosis: A Systematic Review of Preclinical and Clinical Evidence. Nanomaterials (Basel). 2021;11(2)doi: 10.3390/nano11020530.
Salamanna, F., Gambardella, A., Contartese, D., Visani, A., & Fini, M. (2021). Nano-Based Biomaterials as Drug Delivery Systems Against Osteoporosis: A Systematic Review of Preclinical and Clinical Evidence. Nanomaterials (Basel, Switzerland), 11(2), . https://doi.org/10.3390/nano11020530
Salamanna, Francesca, et al. "Nano-Based Biomaterials as Drug Delivery Systems Against Osteoporosis: A Systematic Review of Preclinical and Clinical Evidence." Nanomaterials (Basel, Switzerland) vol. 11,2 (2021). doi: https://doi.org/10.3390/nano11020530
Salamanna F, Gambardella A, Contartese D, Visani A, Fini M. Nano-Based Biomaterials as Drug Delivery Systems Against Osteoporosis: A Systematic Review of Preclinical and Clinical Evidence. Nanomaterials (Basel). 2021 Feb 19;11(2). doi: 10.3390/nano11020530. PMID: 33669621; PMCID: PMC7922277.
Copy Download .nbib Format: NLM
A prognostic model for patients with lymphoma and COVID-19: a multicentre cohort study.

Blood advances

Visco C, Marcheselli L, Mina R, Sassone M, Guidetti A, Penna D, Cattaneo C, Bonuomo V, Busca A, Ferreri AJM, Bruna R, Petrucci L, Cairoli R, Salvini M, Bertù L, Ladetto M, Pilerci S, Pinto A, Ramadan S, Marchesi F, Cavo M, Arcaini L, Coviello E, Romano A, Musto P, Massaia M, Fracchiolla N, Marchetti M, Scattolin A, Tisi MC, Cuneo A, Della Porta M, Trentin L, Turrini M, Gherlinzoni F, Tafuri A, Galimberti S, Bocchia M, Cardinali V, Cilloni D, Corso A, Armiento D, Rigacci L, La Barbera EO, Gambacorti-Passerini C, Visani G, Vallisa D, Venditti A, Selleri C, Conconi A, Tosi P, Lanza F, Candoni A, Krampera M, Corradini P, Passamonti F, Merli F.
PMID: 34644385
Blood Adv. 2022 Jan 11;6(1):327-338. doi: 10.1182/bloodadvances.2021005691.

Lymphoma represents a heterogeneous hematological malignancy (HM), which is characterized by severe immunosuppression. Patients diagnosed of coronavirus disease 2019 (COVID-19) during the course of HM have been described to have poor outcome, with only few reports specifically addressing lymphoma...

Cite
Visco C, Marcheselli L, Mina R, et al. A prognostic model for patients with lymphoma and COVID-19: a multicentre cohort study. Blood Adv. 2022;6(1):327-338doi: 10.1182/bloodadvances.2021005691.
Visco, C., Marcheselli, L., Mina, R., Sassone, M., Guidetti, A., Penna, D., Cattaneo, C., Bonuomo, V., Busca, A., Ferreri, A. J. M., Bruna, R., Petrucci, L., Cairoli, R., Salvini, M., Bertù, L., Ladetto, M., Pilerci, S., Pinto, A., Ramadan, S., Marchesi, F., Cavo, M., Arcaini, L., Coviello, E., Romano, A., Musto, P., Massaia, M., Fracchiolla, N., Marchetti, M., Scattolin, A., Tisi, M. C., Cuneo, A., Della Porta, M., Trentin, L., Turrini, M., Gherlinzoni, F., Tafuri, A., Galimberti, S., Bocchia, M., Cardinali, V., Cilloni, D., Corso, A., Armiento, D., Rigacci, L., La Barbera, E. O., Gambacorti-Passerini, C., Visani, G., Vallisa, D., Venditti, A., Selleri, C., Conconi, A., Tosi, P., Lanza, F., Candoni, A., Krampera, M., Corradini, P., Passamonti, F., Merli, F. (2022). A prognostic model for patients with lymphoma and COVID-19: a multicentre cohort study. Blood advances, 6(1), 327-338. https://doi.org/10.1182/bloodadvances.2021005691
Visco, Carlo, et al. "A prognostic model for patients with lymphoma and COVID-19: a multicentre cohort study." Blood advances vol. 6,1 (2022): 327-338. doi: https://doi.org/10.1182/bloodadvances.2021005691
Visco C, Marcheselli L, Mina R, Sassone M, Guidetti A, Penna D, Cattaneo C, Bonuomo V, Busca A, Ferreri AJM, Bruna R, Petrucci L, Cairoli R, Salvini M, Bertù L, Ladetto M, Pilerci S, Pinto A, Ramadan S, Marchesi F, Cavo M, Arcaini L, Coviello E, Romano A, Musto P, Massaia M, Fracchiolla N, Marchetti M, Scattolin A, Tisi MC, Cuneo A, Della Porta M, Trentin L, Turrini M, Gherlinzoni F, Tafuri A, Galimberti S, Bocchia M, Cardinali V, Cilloni D, Corso A, Armiento D, Rigacci L, La Barbera EO, Gambacorti-Passerini C, Visani G, Vallisa D, Venditti A, Selleri C, Conconi A, Tosi P, Lanza F, Candoni A, Krampera M, Corradini P, Passamonti F, Merli F. A prognostic model for patients with lymphoma and COVID-19: a multicentre cohort study. Blood Adv. 2022 Jan 11;6(1):327-338. doi: 10.1182/bloodadvances.2021005691. PMID: 34644385; PMCID: PMC8516438.
Copy Download .nbib Format: NLM
Factors affecting functional outcome after anterior cervical discectomy and fusion: A multicenter study.

Journal of craniovertebral junction & spine

Scerrati A, Germano' A, Montano N, Visani J, Cacciola F, Raffa G, Ghetti I, Pignotti F, Cavallo MA, Olivi A, de Bonis P.
PMID: 34194160
J Craniovertebr Junction Spine. 2021 Apr-Jun;12(2):144-148. doi: 10.4103/jcvjs.jcvjs_1_21. Epub 2021 Jun 10.

BACKGROUND: Although anterior cervical discectomy and fusion (ACDF) represents a standardized procedure for surgical treatment of a cervical herniated disc, several variables could affect patients' clinical and radiological outcome. We evaluated the impact of sex, age, body mass index...

Cite
Scerrati A, Germano' A, Montano N, et al. Factors affecting functional outcome after anterior cervical discectomy and fusion: A multicenter study. J Craniovertebr Junction Spine. 2021;12(2):144-148doi: 10.4103/jcvjs.jcvjs_1_21.
Scerrati, A., Germano', A., Montano, N., Visani, J., Cacciola, F., Raffa, G., Ghetti, I., Pignotti, F., Cavallo, M. A., Olivi, A., & de Bonis, P. (2021). Factors affecting functional outcome after anterior cervical discectomy and fusion: A multicenter study. Journal of craniovertebral junction & spine, 12(2), 144-148. https://doi.org/10.4103/jcvjs.jcvjs_1_21
Scerrati, Alba, et al. "Factors affecting functional outcome after anterior cervical discectomy and fusion: A multicenter study." Journal of craniovertebral junction & spine vol. 12,2 (2021): 144-148. doi: https://doi.org/10.4103/jcvjs.jcvjs_1_21
Scerrati A, Germano' A, Montano N, Visani J, Cacciola F, Raffa G, Ghetti I, Pignotti F, Cavallo MA, Olivi A, de Bonis P. Factors affecting functional outcome after anterior cervical discectomy and fusion: A multicenter study. J Craniovertebr Junction Spine. 2021 Apr-Jun;12(2):144-148. doi: 10.4103/jcvjs.jcvjs_1_21. Epub 2021 Jun 10. PMID: 34194160; PMCID: PMC8214232.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 141 entries